Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Price:
5.9
USD
2.79%
Market Closed
Market Cap:
$9.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
IL |
|
Yuxing Infotech Investment Holdings Ltd
HKEX:8005
|
HK |
|
Almadex Minerals Ltd
XTSX:DEX
|
CA |
|
Nilorngruppen AB
STO:NIL B
|
SE |
|
Rallis India Ltd
NSE:RALLIS
|
IN |
|
A
|
Ashapura Minechem Ltd
NSE:ASHAPURMIN
|
IN |
|
Chahua Modern Housewares Co Ltd
SSE:603615
|
CN |
|
Axiom Properties Ltd
ASX:AXI
|
AU |
|
Catcher Technology Co Ltd
TWSE:2474
|
TW |
|
Lotte Fine Chemical Co Ltd
KRX:004000
|
KR |
|
A
|
American Express Co
BMV:AXP
|
US |
|
Nine Dragons Paper (Holdings) Ltd
HKEX:2689
|
HK |
|
Soup Holdings Ltd
SGX:5KI
|
SG |
|
Endo Lighting Corp
TSE:6932
|
JP |
|
T
|
Tarkett SA
PAR:TKTT
|
FR |
|
G
|
Genpharmasec Ltd
BSE:531592
|
IN |
|
Indigo Books and Music Inc
TSX:IDG
|
CA |
|
Reconnaissance Energy (Africa) Ltd
XTSX:RECO
|
CA |
|
Canadian Natural Resources Ltd
TSX:CNQ
|
CA |
|
E
|
EIT Environmental Development Group Co Ltd
SZSE:300815
|
CN |
|
Xelpmoc Design and Tech Ltd
NSE:XELPMOC
|
IN |
|
Cigna Corp
NYSE:CI
|
US |
|
Kedge Construction Co Ltd
TWSE:2546
|
TW |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of QNRX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QNRX
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
QNRX Competitors Multiples
Quoin Pharmaceuticals Ltd Competitors
Quoin Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
9.5m USD | 0 | -0.3 | -0.5 | -0.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
992.2B USD | 347.4 | 4 113.7 | 1 178.7 | 2 269.8 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
186.6B USD | 4.2 | 27.8 | 19.3 | 25.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
134B USD | 5.5 | 37.1 | 18.9 | 27.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
317.3B CNY | 6.9 | 16.4 | 17.2 | 17.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.3B CHF | 5.3 | -126.1 | 17.1 | 26.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.5B USD | 4.6 | 25.2 | 18.5 | 21.9 | |
| US |
|
Waters Corp
NYSE:WAT
|
31.4B USD | 9.9 | 48.8 | 31.5 | 39.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.4B USD | 1.7 | 21 | 11.7 | 17.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 6.7 | 31 | 23 | 25.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
